Charles River Laboratories Announces Plan to Construct New Preclinical Services Facility in Quebec

29-Aug-2007

Charles River Laboratories International, Inc. announced that it intends to build a new facility in Sherbrooke, Quebec, to support the company's expanding Preclinical services business. Located in the newly constructed Sherbrooke Biomedical Park, Charles River's newest facility shall provide essential drug discovery and development services to the international pharmaceutical and biopharmaceutical industries.

When completed, the new facility will be approximately 300,000 square feet. Approximately 25 percent will be constructed in the first phase and is expected to be dedicated to one or two clients. The first phase is scheduled to be opened by the first quarter of 2009. Timing of construction of the remaining phases will be dependent on market demand. The Sherbrooke facility is ultimately expected to employ 1,000 people, who will work collaboratively with the 1,600 staff currently located in the company's Montreal facility.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance